Revance Therapeutics, Inc. (RVNC)
NASDAQ: RVNC · Real-Time Price · USD
3.680
+0.410 (12.54%)
At close: Jan 17, 2025, 4:00 PM
3.690
+0.010 (0.27%)
After-hours: Jan 17, 2025, 6:35 PM EST
Revance Therapeutics Employees
Revance Therapeutics had 597 employees as of December 31, 2023. The number of employees increased by 63 or 11.80% compared to the previous year.
Employees
597
Change (1Y)
63
Growth (1Y)
11.80%
Revenue / Employee
$430,394
Profits / Employee
-$308,943
Market Cap
386.04M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
RVNC News
- 19 hours ago - The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Revance Therapeutics, Inc. - Accesswire
- 23 hours ago - Investors in Revance Therapeutics, Inc. Should Contact The Gross Law Firm Before March 4, 2025 to Discuss Your Rights - RVNC - PRNewsWire
- 1 day ago - Revance Therapeutics, Inc. Is Being Sued For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm - Accesswire
- 3 days ago - Revance Therapeutics, Inc. Is Being Sued For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm - Accesswire
- 4 days ago - Revance Therapeutics, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before March 4, 2025 to Discuss Your Rights - RVNC - PRNewsWire
- 5 days ago - Shareholders of Revance Therapeutics, Inc. Should Contact The Gross Law Firm Before March 4, 2025 to Discuss Your Rights - RVNC - GlobeNewsWire
- 5 days ago - Revance Therapeutics Inc. Is Being Sued For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm - Accesswire
- 7 days ago - Revance Therapeutics Inc Is Being Sued For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm - Accesswire